The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For more information on how The Conference Board collects and uses personal data, please visit our privacy policy. By continuing to use this Site or by clicking "OK", you consent to the use of cookies. 
HIV/AIDS in the Workplace Corporate Strategies and Responses: An Update

In 2007, more than 82 percent of companies globally had prevention and/or treatment programs, up from 73 percent in 1997. The challenges to such programs, whether they are in low-prevalence areas such as North America and Western Europe or high-prevalence sub-Saharan Africa, are the same: lack of funds and personnel and corporate and employee resistance. Benefits of AIDS/HIV programs are hard to quantify, but companies who invest in them from the top down and whose C-suite executives lead in their development will find benefits in increased morale and decreased absenteeism, as well as a potential boost to the bottom line.

Pricing